RKLIF: Executive acquires 8,997 shares in Dividend Reinvestment Plan

Rhea-AI Filing Summary

Rentokil Initial plc reports that on 23 September 2025 Andy Ransom, a Person Discharging Managerial Responsibility, acquired 8,997 ordinary shares of 1 pence each through the company's Dividend Reinvestment Plan at a price of £3.616967 per share. The disclosure is made under Article 19 of the UK Market Abuse Regulation and was communicated by the Group General Counsel and Company Secretary. The filing provides the transaction price, share count and the date of acquisition but does not disclose Mr. Ransom's resulting total shareholding or any other related transactions.

Insights

Corporate Governance Expert

TL;DR: An insider used the DRIP to take additional shares, a routine disclosure that signals alignment but is not materially transformative.

The filing documents a standard, compliant notification of an executive's participation in the Dividend Reinvestment Plan, showing 8,997 shares bought at £3.616967. This is a routine internal capital allocation mechanism rather than an open-market purchase or sale. The information is important for regulatory transparency but lacks context on the executive's total holdings, percentage ownership, or any market-moving scale. For governance review, this confirms plan operation and insider engagement but does not by itself indicate a change in control, compensation structure, or corporate strategy.

Securities Compliance Analyst

TL;DR: The disclosure meets MAR notification standards; transaction details are clear but immaterial for valuation on their own.

This Form 6-K supplies the required elements: identity of the PDML, transaction date (23 September 2025), number of shares (8,997) and execution price (£3.616967). From a compliance perspective, the filing appears complete for the single DRIP transaction disclosed, though it does not state the insider's aggregate holding post-transaction. The disclosure reduces regulatory risk by timely reporting, but the scale of the purchase is small and unlikely to influence market pricing or investor valuation materially.

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

___________________

FORM 6-K

__________________

REPORT OF FOREIGN PRIVATE ISSUER

PURSUANT TO RULE 13a-16 OR 15d-16

UNDER THE SECURITIES EXCHANGE ACT OF 1934

For the month of September 2025

Commission File Number: 001-41524

___________________________________

Rentokil Initial plc

(Registrant’s name)

___________________________________

Compass House

Manor Royal

Crawley

West Sussex RH10 9PY

United Kingdom

(Address of principal executive office)

_____________________________________

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

Form 20-F ☒ Form 40-F ☐

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ☐

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ☐

Director/PDMR Shareholding dated 25 September 2025

Rentokil Initial plc

Rentokil Initial plc (the 'Company') has been informed that on 23 September 2025 Andy Ransom, a Person Discharging Managerial Responsibility, acquired 8,997 ordinary shares of 1 pence in the Company as a result of his participation in the Company's Dividend Reinvestment Plan (DRIP). The shares were purchased at £3.616967 per share.

The notification set out below is provided in accordance with the requirements of Article 19 of the UK Market Abuse Regulation.

Rachel Canham

Group General Counsel & Company Secretary

+44 (0)1293 858 000

1	Details of the person discharging managerial responsibilities / person closely associated
a)	Name	Andy Ransom
2	Reason for the notification
a)	Position/status	Chief Executive
b)	Initial notification /Amendment	Initial notification
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	Rentokil Initial plc
b)	LEI	549300VN4WV7Z6T14K68
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument Identification code	Ordinary shares of 1p each ISIN: GB00B082RF11
b)	Nature of the transaction	Acquisition of shares through the Company's Dividend Reinvestment Plan (DRIP).
c)	Price(s) and volume(s)	Price(s)	Volume(s)
		£3.616967	8,997
d)	Aggregated information - Aggregated volume - Total price	8,997 £32,541.85
e)	Date of the transaction	2025-09-23
f)	Place of the transaction	London Stock Exchange (XLON)

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

Date: 25 September 2025	RENTOKIL INITIAL PLC
	/s/ Rachel Canham
	Name: Rachel Canham
	Title: Group General Counsel and Company Secretary

FAQ

What transaction did Rentokil Initial (RKLIF) disclose in this Form 6-K?

The filing reports that Andy Ransom acquired 8,997 ordinary shares through the company's Dividend Reinvestment Plan on 23 September 2025.

At what price were the Rentokil Initial shares purchased in the DRIP?

The shares were purchased at £3.616967 per share.

Who made the disclosure on behalf of Rentokil Initial?

The disclosure was provided by Rachel Canham, Group General Counsel & Company Secretary.

Does the filing state Andy Ransom's total shareholding after the acquisition?

No. The filing specifies only the number of shares acquired and the price; it does not disclose his resulting total holding.

Under what regulation was this notification made?

The notification was made in accordance with Article 19 of the UK Market Abuse Regulation.